- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CD20 antibody recognizes CD20, also known as Membrane spanning 4-domains subfamily A member 1, a B-cell specific transmembrane phosphoprotein encoded by the MS4A1 gene. CD20 is localized to the plasma membrane of B lymphocytes, where it plays a role in regulating B-cell activation, proliferation, and calcium signaling. CD20 Antibody Recombinant Mouse MAb is developed to support research in B-cell immunology, lymphoma biology, and therapeutic antibody development.
The MS4A1 gene is located on chromosome 11q12.2 and encodes a protein with four transmembrane domains and short cytoplasmic N- and C-terminal regions. CD20 expression begins at the late pre-B-cell stage and persists through mature B cells but is absent on hematopoietic stem cells and terminally differentiated plasma cells. This restricted expression pattern makes CD20 a widely used marker for identifying B-cell populations in lymphoid tissues such as tonsil, spleen, and lymph node.
Functionally, CD20 is associated with the B-cell receptor complex and contributes to calcium influx following antigen engagement. Although CD20 does not have a clearly defined soluble ligand, it participates in membrane microdomains that regulate signal transduction and cell cycle progression. Dysregulated CD20 expression is observed in B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia, and other lymphoproliferative disorders. CD20 Antibody Recombinant Mouse MAb enables evaluation of CD20 distribution and density in both normal and malignant B-cell populations.
CD20 is also a major therapeutic target in oncology and autoimmune disease. Anti-CD20 monoclonal antibodies are used clinically to induce B-cell depletion through complement activation, antibody-dependent cellular cytotoxicity, and apoptotic mechanisms. Ongoing research continues to investigate CD20 modulation, resistance mechanisms, and expression heterogeneity in treated patients. Clone rMS4A1/8044 is engineered as a recombinant mouse monoclonal antibody to provide consistent specificity and reproducibility in CD20 detection.
By targeting a clinically significant B-cell surface antigen, CD20 Antibody Recombinant Mouse MAb supports studies in lymphoma classification, immune regulation, and translational research focused on CD20-directed therapies.
Optimal dilution of the CD20 antibody should be determined by the researcher.
A recombinant partial protein (within amino acids 200-297) from the human protein was used as the immunogen for the CD20 antibody.
Aliquot the CD20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.